How to buy Sienna Cancer Diagnostics shares
Own Sienna Cancer Diagnostics shares in just a few minutes.
We’re committed to our readers and editorial independence. We don’t compare all products in the market and may receive compensation when we refer you to our partners, but this does not influence our opinions or reviews. Learn more about Finder.
Sienna Cancer Diagnostics Limited is a diagnostics & research business based in Australia. Sienna Cancer Diagnostics shares (SDX) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Sienna Cancer Diagnostics has a trailing 12-month revenue of around $999,521.
How to buy shares in Sienna Cancer Diagnostics
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Sienna Cancer Diagnostics . Find the share by name or ticker symbol: SDX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Sienna Cancer Diagnostics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $N/A, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Sienna Cancer Diagnostics . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
🧪How we chose these brokersFor our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.
What's in this guide?
- Sienna Cancer Diagnostics key stats
- Compare share trading platforms
- Is Sienna Cancer Diagnostics stock a buy or sell?
- Sienna Cancer Diagnostics performance over time
- Sienna Cancer Diagnostics 's financials
- How volatile are Sienna Cancer Diagnostics shares?
- Does Sienna Cancer Diagnostics pay a dividend?
- Other common questions
Sienna Cancer Diagnostics share priceUse our graph to track the performance of SDX stocks over time.
Sienna Cancer Diagnostics shares at a glance
|52-week range||AUDA$0.02 - AUDA$0.08|
|50-day moving average||AUDA$0.0692|
|200-day moving average||AUDA$0.0519|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||AUDA$-0.011|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy Sienna Cancer Diagnostics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Sienna Cancer Diagnostics financials
|Gross profit TTM||$989,610|
|Return on assets TTM||-20.32%|
|Return on equity TTM||-35.97%|
|Market capitalisation||$27.7 million|
TTM: trailing 12 months
Sienna Cancer Diagnostics share dividends
We're not expecting Sienna Cancer Diagnostics to pay a dividend over the next 12 months.
Sienna Cancer Diagnostics share price volatility
Over the last 12 months, Sienna Cancer Diagnostics 's shares have ranged in value from as little as $0.02 up to $0.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Sienna Cancer Diagnostics 's is 3.007. This would suggest that Sienna Cancer Diagnostics 's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Sienna Cancer Diagnostics overview
Sienna Cancer Diagnostics Limited, a medical technology company, identifies, develops, and commercializes cancer-related in-vitro diagnostic tests for use in pathology laboratories worldwide. The company offers SCD-A7, an anti-human telomerase reverse transcriptase antibody for the detection of the biomarker for cancer. It also provides SIEN-NET technology, a sample preparation platform to enhance the performance of liquid biopsy diagnostic assays. The company has a research collaboration agreement with Minomic International Ltd to develop a proprietary test for the early detection of pancreatic cancer. The company was formerly known as Sienna Capital Ltd and changed its name to Sienna Cancer Diagnostics Limited in 2006. Sienna Cancer Diagnostics Limited was founded in 2002 and is headquartered in Scoresby, Australia.
Frequently asked questions
More guides on Finder
How to invest in the Harmoney (SDX.AU) IPO
Everything we know about the Harmoney IPO, plus information on how to buy in.
How to invest in the Youfoodz (SDX.AU) IPO
Everything we know about the Youfoodz IPO, plus information on how to buy in.
How to invest in the Hipages (SDX.AU) IPO
Everything we know about the Hipages IPO, plus information on how to buy in.
How to buy the US Vegan Climate ETF | N/AN/A
Steps to owning and managing buy US Vegan Climate ETF units.
How to buy Roots Sustainable Agricultural Technologies shares | A$0.023
Steps to owning and managing Roots Sustainable Agricultural Technologies shares from Australia.
How to buy Sienna Cancer Diagnostics shares | $56.73
Steps to owning and managing Bunge Ltd shares from Australia.
How to buy Sienna Cancer Diagnostics shares | $37.47
Steps to owning and managing Conagra Brands shares from Australia.
How to buy Sienna Cancer Diagnostics shares | $67.1
Steps to owning and managing Kellogg Company shares from Australia.
How to buy Sienna Cancer Diagnostics shares | $70.89
Steps to owning and managing Ingredion shares from Australia
How to buy Sienna Cancer Diagnostics shares | $59.71
Steps to owning and managing Tyson Foods shares from Australia.
Ask an Expert